Lexaria Net Working Capital vs Retained Earnings Analysis

Stocks . USA . 
Stock . Lexaria Bioscience Corp
LEXX Stock  USD 2.13  0.02  0.93%   
Lexaria Bioscience financial indicator trend analysis is infinitely more than just investigating Lexaria Bioscience Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lexaria Bioscience Corp is a good investment. Please check the relationship between Lexaria Bioscience Net Working Capital and its Retained Earnings accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexaria Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Net Working Capital vs Retained Earnings

Net Working Capital vs Retained Earnings Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Lexaria Bioscience Corp Net Working Capital account and Retained Earnings. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Lexaria Bioscience's Net Working Capital and Retained Earnings is -0.21. Overlapping area represents the amount of variation of Net Working Capital that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of Lexaria Bioscience Corp, assuming nothing else is changed. The correlation between historical values of Lexaria Bioscience's Net Working Capital and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Working Capital of Lexaria Bioscience Corp are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Net Working Capital i.e., Lexaria Bioscience's Net Working Capital and Retained Earnings go up and down completely randomly.

Correlation Coefficient

-0.21
Relationship DirectionNegative 
Relationship StrengthInsignificant

Net Working Capital

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.
Most indicators from Lexaria Bioscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lexaria Bioscience Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexaria Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
At this time, Lexaria Bioscience's Issuance Of Capital Stock is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 415.56 in 2024, whereas Selling General Administrative is likely to drop slightly above 2.4 M in 2024.

Lexaria Bioscience fundamental ratios Correlations

Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Cash And Short Term Investments
Common Stock Total Equity
Common Stock Shares Outstanding
Non Current Liabilities Total
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Common Stock
Short Long Term Debt Total
Current Deferred Revenue
Net Receivables
Short Term Debt
Inventory
Non Currrent Assets Other
Total Assets
-0.130.060.980.13-0.87-0.450.040.930.220.940.35-0.070.030.320.520.070.220.93-0.44-0.12-0.640.58-0.11-0.36-0.17
Other Current Liab
-0.13-0.12-0.11-0.310.11-0.560.72-0.13-0.18-0.120.550.070.630.570.56-0.06-0.16-0.09-0.11-0.42-0.420.12-0.44-0.38-0.2
Total Current Liabilities
0.06-0.12-0.110.960.420.30.22-0.270.95-0.26-0.51-0.270.13-0.31-0.251.00.96-0.28-0.30.570.120.160.570.41-0.2
Total Stockholder Equity
0.98-0.11-0.11-0.04-0.94-0.50.00.980.060.980.42-0.02-0.010.380.56-0.10.050.98-0.4-0.23-0.670.54-0.21-0.42-0.15
Property Plant And Equipment Net
0.13-0.310.96-0.040.350.330.1-0.20.97-0.2-0.55-0.290.02-0.4-0.290.950.97-0.22-0.270.650.160.190.650.42-0.12
Net Debt
-0.870.110.42-0.940.350.450.17-0.990.28-0.99-0.48-0.020.14-0.34-0.480.410.28-0.990.210.360.57-0.410.350.460.05
Retained Earnings
-0.45-0.560.3-0.50.330.45-0.6-0.440.14-0.44-0.88-0.19-0.6-0.89-0.970.240.15-0.490.250.60.81-0.480.620.630.37
Accounts Payable
0.040.720.220.00.10.17-0.6-0.110.25-0.10.410.140.850.670.660.280.29-0.08-0.49-0.15-0.610.07-0.19-0.44-0.23
Cash
0.93-0.13-0.270.98-0.2-0.99-0.44-0.11-0.121.00.43-0.01-0.10.330.49-0.26-0.131.0-0.3-0.28-0.60.46-0.27-0.43-0.08
Non Current Assets Total
0.22-0.180.950.060.970.280.140.25-0.12-0.12-0.38-0.260.2-0.21-0.080.950.99-0.13-0.360.57-0.010.280.560.28-0.17
Cash And Short Term Investments
0.94-0.12-0.260.98-0.2-0.99-0.44-0.11.0-0.120.43-0.01-0.10.330.49-0.26-0.121.0-0.31-0.28-0.60.46-0.27-0.43-0.08
Common Stock Total Equity
0.350.55-0.510.42-0.55-0.48-0.880.410.43-0.380.430.140.520.740.87-0.46-0.410.470.13-0.76-0.560.49-0.8-0.55-0.41
Common Stock Shares Outstanding
-0.070.07-0.27-0.02-0.29-0.02-0.190.14-0.01-0.26-0.010.140.130.350.19-0.26-0.230.01-0.13-0.37-0.2-0.2-0.350.03-0.19
Non Current Liabilities Total
0.030.630.13-0.010.020.14-0.60.85-0.10.2-0.10.520.130.60.650.210.2-0.08-0.19-0.24-0.440.22-0.28-0.38-0.3
Other Current Assets
0.320.57-0.310.38-0.4-0.34-0.890.670.33-0.210.330.740.350.60.91-0.26-0.180.37-0.47-0.55-0.870.15-0.55-0.66-0.25
Other Stockholder Equity
0.520.56-0.250.56-0.29-0.48-0.970.660.49-0.080.490.870.190.650.91-0.19-0.080.53-0.35-0.54-0.860.47-0.56-0.68-0.32
Total Liab
0.07-0.061.0-0.10.950.410.240.28-0.260.95-0.26-0.46-0.260.21-0.26-0.190.96-0.27-0.310.540.080.190.550.37-0.22
Property Plant And Equipment Gross
0.22-0.160.960.050.970.280.150.29-0.130.99-0.12-0.41-0.230.2-0.18-0.080.96-0.14-0.430.58-0.050.220.580.24-0.15
Total Current Assets
0.93-0.09-0.280.98-0.22-0.99-0.49-0.081.0-0.131.00.470.01-0.080.370.53-0.27-0.14-0.3-0.32-0.630.49-0.31-0.44-0.11
Common Stock
-0.44-0.11-0.3-0.4-0.270.210.25-0.49-0.3-0.36-0.310.13-0.13-0.19-0.47-0.35-0.31-0.43-0.3-0.30.730.12-0.320.44-0.22
Short Long Term Debt Total
-0.12-0.420.57-0.230.650.360.6-0.15-0.280.57-0.28-0.76-0.37-0.24-0.55-0.540.540.58-0.32-0.30.3-0.191.00.060.66
Current Deferred Revenue
-0.64-0.420.12-0.670.160.570.81-0.61-0.6-0.01-0.6-0.56-0.2-0.44-0.87-0.860.08-0.05-0.630.730.3-0.240.30.720.12
Net Receivables
0.580.120.160.540.19-0.41-0.480.070.460.280.460.49-0.20.220.150.470.190.220.490.12-0.19-0.24-0.21-0.1-0.39
Short Term Debt
-0.11-0.440.57-0.210.650.350.62-0.19-0.270.56-0.27-0.8-0.35-0.28-0.55-0.560.550.58-0.31-0.321.00.3-0.210.090.66
Inventory
-0.36-0.380.41-0.420.420.460.63-0.44-0.430.28-0.43-0.550.03-0.38-0.66-0.680.370.24-0.440.440.060.72-0.10.09-0.39
Non Currrent Assets Other
-0.17-0.2-0.2-0.15-0.120.050.37-0.23-0.08-0.17-0.08-0.41-0.19-0.3-0.25-0.32-0.22-0.15-0.11-0.220.660.12-0.390.66-0.39
Click cells to compare fundamentals

Lexaria Bioscience Account Relationship Matchups

High Positive Relationship

Total Liab
+ 1.0
Total Current Liabilities
Cash And Short Term Investments
+ 1.0
Cash
Total Current Assets
+ 1.0
Cash
Total Current Assets
+ 1.0
Cash And Short Term Investments
Short Term Debt
+ 1.0
Short Long Term Debt Total
Property Plant And Equipment Gross
+ 0.99
Non Current Assets Total

High Negative Relationship

Total Current Assets
- 0.99
Net Debt
Cash And Short Term Investments
- 0.99
Net Debt
Cash
- 0.99
Net Debt
Other Stockholder Equity
- 0.97
Retained Earnings
Net Debt
- 0.94
Total Stockholder Equity
Other Current Assets
- 0.89
Retained Earnings

Lexaria Bioscience fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.8M13.3M7.8M3.1M3.5M4.1M
Other Current Liab96.7K45K51.7K239.9K275.9K289.7K
Total Current Liabilities225.9K153.3K194.0K267.7K241.0K472.9K
Total Stockholder Equity2.5M13.3M7.9M3.0M3.5M3.4M
Property Plant And Equipment Net610.3K459.3K367.9K421.6K379.4K360.5K
Net Debt(1.1M)(10.8M)(5.8M)(1.2M)(1.1M)(1.1M)
Retained Earnings(27.8M)(31.8M)(39.1M)(45.8M)(41.2M)(39.1M)
Accounts Payable45.1K59.9K25.8K225.0K258.8K271.7K
Cash1.3M10.9M5.8M1.4M1.6M1.8M
Non Current Assets Total902.3K823.9K856.4K884.2K795.8K1.3M
Cash And Short Term Investments1.3M11.8M6.2M1.5M1.7M1.8M
Common Stock Shares Outstanding2.8M4.4M5.9M6.6M7.6M8.0M
Liabilities And Stockholders Equity2.8M13.3M7.8M3.1M3.5M4.1M
Non Current Liabilities Total120.1K50.0K7.4K136.2K122.6K216.6K
Other Current Assets182.1K319.3K576.8K546.8K628.8K660.2K
Other Stockholder Equity30.3M45.1M47.0M48.8M56.1M58.9M
Total Liab346.0K203.3K201.4K403.9K363.5K556.3K
Property Plant And Equipment Gross483.4K773.2K747.9K896.8K807.1K1.4M
Total Current Assets1.9M12.4M7.0M2.2M2.5M2.2M
Common Stock90.0K5.7K6.0K8.1K9.3K8.8K
Net Receivables313.9K342.4K201.8K175.2K201.5K166.0K
Inventory116.9K29.6K38.4K1.00.90.86
Non Currrent Assets Other(902.3K)(823.9K)(856.4K)(884.2K)(795.8K)(835.6K)
Intangible Assets292K364.6K488.5K462.6K532.0K558.6K
Net Tangible Assets2.1M2.2M12.9M7.5M8.6M5.5M
Net Invested Capital2.6M13.3M7.9M3.0M3.5M5.4M
Net Working Capital1.7M12.3M6.8M1.9M2.2M2.1M
Property Plant Equipment591.3K610.3K459.3K367.9K423.1K372.5K
Short Term Investments19.3K833.8K347.3K125.6K144.5K256.8K
Capital Stock90.0K5.7K6.0K8.1K7.3K6.9K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
RSIRush Street Interactive
OKTAOkta Inc
BACBank of America

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY